- Home
- / Premier Biomedical
Premier Biomedical
Stock Price
$0
2024-10-29
Market Capitalization
$1 M
2024-10-29
Revenue
$14.3 K
FY, 2019
Premier Biomedical Summary
Company Summary
- Overview
- Premier Biomedical, Inc. is a research-based firm that develops cures for Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer’s Disease, Blood Sepsis, Atherosclerosis, and Cancer.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Jackson Center, PA, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Mitchell S. Felder, Chairman of the Board of Directors
Heidi H. Carl, Chief Financial Officer and Board Member
Patricio F. Reyes, Chief Technical Officer, Board Member
LocationsView all
1 location detected
Jackson Center, PA HQ
United States
Jackson Center, PA 16133, USA
Premier Biomedical Financials
Summary Financials
- Revenue (FY, 2019)
- $14.3K
- Gross profit (FY, 2019)
- $1.4K
- Net income (FY, 2019)
- ($374.5K)
- Cash (FY, 2019)
- $71.2K
- EBIT (FY, 2019)
- ($326.7K)
- Enterprise value
- $1.0M